Frequency Therapeutics Inc.

0.3813-0.0137-3.47%Vol 28.29K1Y Perf -78.06%
Sep 22nd, 2023 15:59 DELAYED
BID0.3813 ASK0.4280
Open0.3811 Previous Close0.3950
Pre-Market- After-Market-
 - -  - -%
Target Price
6.75 
Analyst Rating
Strong Buy 1.00
Potential %
1.67K 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12 mo.
-100/-100/-100 
Value Ranking
★+     44.44
Insiders Value % 3/6/12 mo.
-100/-100/-100 
Growth Ranking
★+     43.39
Insiders Shares Cnt. % 3/6/12 mo.
-100/-100/-100 
Income Ranking
 —    -
Price Range Ratio 52W %
1.05 
Earnings Rating
Market Cap13.93M 
Earnings Date
14th Nov 2023
Alpha-0.01 Standard Deviation0.29
Beta0.70 

Today's Price Range

0.38110.4299

52W Range

0.32585.59

Summary:

Sell

Technical Indicators: Neutral
Moving Averages: Strong Sell
Performance
1 Week
-10.07%
1 Month
-23.59%
3 Months
12.81%
6 Months
-14.31%
1 Year
-78.06%
3 Years
-98.13%
5 Years
-
10 Years
-

TickerPriceChg.Chg.%
FREQ0.3813-0.0137-3.47
AAPL174.790.86000.49
GOOG131.25-0.1100-0.08
MSFT317.01-2.5200-0.79
XOM114.940.18000.16
WFC41.23-1.0900-2.58
JNJ160.50-1.1600-0.72
FB196.640.99000.51
GE111.25-1.7400-1.54
JPM145.73-1.4100-0.96
Financial StrengthValueIndustryS&P 500US Markets
5.00
5.00
0.29
0.54
-102.20
Leverage Ratio 1.60
ProfitabilityValueIndustryS&P 500US Markets
-
-923.30
-890.20
-
-72.67
RevenueValueIndustryS&P 500US Markets
0.00
0.00
-
-
Earnings HistoryEstimateReportedSurprise %
Q02 2023-0.44-0.3031.82
Q01 2023-0.39-0.55-41.03
Q04 2022-0.65-0.4924.62
Q03 2022-0.61-0.559.84
Q02 2022-0.69-0.6111.59
Q01 2022-0.66-0.67-1.52
Q04 20210.37-0.62-267.57
Q03 2021-0.55-0.73-32.73
Earnings Per EndEstimateRevision %Trend
----
----
----
----
Next Report Date14th Nov 2023
Estimated EPS Next Report-
Estimates Count-
EPS Growth Next 5 Years %-
Volume Overview
Volume28.29K
Shares Outstanding36.52K
Shares Float35.36M
Trades Count270
Dollar Volume11.22K
Avg. Volume637.49K
Avg. Weekly Volume96.58K
Avg. Monthly Volume114.58K
Avg. Quarterly Volume1.70M

Frequency Therapeutics Inc. (NASDAQ: FREQ) stock closed at 0.3813 per share at the end of the most recent trading day (a -3.47% change compared to the prior day closing price) with a volume of 28.29K shares and market capitalization of 13.93M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Biotechnology industry, Healthcare sector and employs 47 people. Frequency Therapeutics Inc. CEO is David L. Lucchino.

The one-year performance of Frequency Therapeutics Inc. stock is -78.06%, while year-to-date (YTD) performance is -90.1%. FREQ stock has a five-year performance of %. Its 52-week range is between 0.3258 and 5.59, which gives FREQ stock a 52-week price range ratio of 1.05%

Frequency Therapeutics Inc. currently has a PE ratio of -1.40, a price-to-book (PB) ratio of 1.53, a price-to-sale (PS) ratio of 5.42, a price to cashflow ratio of 28.20, a PEG ratio of -, a ROA of -50.69%, a ROC of -53.77% and a ROE of -74.83%. The company’s profit margin is -72.67%, its EBITDA margin is -890.20%, and its revenue ttm is $0.00 , which makes it $0.00 revenue per share.

Of the last four earnings reports from Frequency Therapeutics Inc., there were 3 positive earnings surprise and 1 negative earnings surprise. The company has EPS estimate of $0.00 for the next earnings report. Frequency Therapeutics Inc.’s next earnings report date is 14th Nov 2023.

The consensus rating of Wall Street analysts for Frequency Therapeutics Inc. is Strong Buy (1), with a target price of $6.75, which is +1 670.26% compared to the current price. The earnings rating for Frequency Therapeutics Inc. stock is (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Frequency Therapeutics Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Frequency Therapeutics Inc. has a Sell technical analysis rating based on Technical Indicators (ADX : 23.25, ATR14 : 0.05, CCI20 : -117.72, Chaikin Money Flow : -0.50, MACD : -0.04, Money Flow Index : 21.51, ROC : -15.08, RSI : 29.52, STOCH (14,3) : 9.37, STOCH RSI : 0.38, UO : 22.14, Williams %R : -90.63), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Frequency Therapeutics Inc. in the last 12-months were: Loose Christopher R. (Sold 4 931 shares of value $2 792 ), Lucchino David L. (Sold 9 817 shares of value $5 557 ), Mitrano Richard J. (Sold 832 shares of value $469 ), Richard J. Mitrano (Sold 3 738 shares of value $2 277 )

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
1 (100.00 %)
1 (33.33 %)
1 (25.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
0 (0.00 %)
2 (66.67 %)
3 (75.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingStrong Buy
1.00
Moderate Buy
2.33
Moderate Buy
2.50

Frequency Therapeutics Inc.

Frequency Therapeutics Inc is a clinical-stage biotechnology company focused on harnessing the body's innate biology to repair or reverse damage caused by degenerative diseases. Its Progenitor Cell Activation approach uses combinations of molecules to activate progenitor cells within the body to create functional tissue. Its product candidate FX-322 is being developed for treating sensorineural hearing loss.

CEO: David L. Lucchino

Telephone: +1 866 389-1970

Address: 19 Presidential Way, Woburn 01801, MA, US

Number of employees: 47

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

52%48%

Bearish Bullish

55%45%

Bearish Bullish

57%43%

 

News

Stocktwits